← All companies
CVS
CVS Health Corporation
$104.42
-0.95 -0.90%
Key statistics
from XBRL data in SEC filingsMarket cap
$134B
Revenue (TTM)
$415B
Net income (TTM)
$4.89B
EPS (TTM)
$3.79
P/E ratio
27.6
Dividend yield
2.55%
Free cash flow
$7.81B
Cash
$11.3B
Total assets
$254B
Gross margin
7.1%
52-week range
$61.35 – $110.68
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Aug 5, 2026
8-K
Results of operations (earnings release)
Aug 5, 2026
8-K
Director or officer change; Shareholder vote results
May 18, 2026
10-Q
Quarter ended 2026-03-31
May 6, 2026
8-K
Results of operations (earnings release)
May 6, 2026
8-K
Director or officer change
Mar 19, 2026
10-K
Fiscal year ended 2025-12-31
Feb 10, 2026
8-K
Results of operations (earnings release)
Feb 10, 2026
8-K
Regulation FD disclosure
Dec 9, 2025
8-K
Other events
Nov 20, 2025
10-Q
Quarter ended 2025-09-30
Oct 29, 2025
8-K
Results of operations (earnings release)
Oct 29, 2025
8-K
Other events
Sep 22, 2025
8-K
Other events
Aug 15, 2025
10-Q
Quarter ended 2025-06-30
Jul 31, 2025
8-K
Results of operations (earnings release)
Jul 31, 2025
8-K
Shareholder vote results
May 20, 2025
10-Q
Quarter ended 2025-03-31
May 1, 2025
8-K
Results of operations (earnings release)
May 1, 2025
8-K
Director or officer change; Regulation FD disclosure
Apr 8, 2025
10-K
Fiscal year ended 2024-12-31
Feb 12, 2025
8-K
Results of operations (earnings release)
Feb 12, 2025
8-K
Other events
Dec 17, 2024
8-K
Other events
Dec 10, 2024
8-K
Other events
Dec 9, 2024
8-K
Other events
Dec 6, 2024
8-K
Other events
Dec 5, 2024
8-K
Other events
Dec 2, 2024
8-K
Entered a material agreement; Director or officer change; Regulation FD disclosure
Nov 18, 2024
8-K
Director or officer change; Regulation FD disclosure
Nov 6, 2024
10-Q
Quarter ended 2024-09-30
Nov 6, 2024
8-K
Results of operations (earnings release)
Nov 6, 2024
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Oct 18, 2024
10-Q
Quarter ended 2024-06-30
Aug 7, 2024
8-K
Results of operations (earnings release)
Aug 7, 2024
8-K
Director or officer change; Shareholder vote results
May 22, 2024
8-K
Other events
May 9, 2024
8-K
Other events
May 8, 2024
10-Q
Quarter ended 2024-03-31
May 1, 2024
8-K
Results of operations (earnings release)
May 1, 2024